-
Sector Analysis
Respiratory Syncytial Virus (RSV) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
RSV Marketed and Pipeline Drugs Report Overview The respiratory syncytial virus was discovered in 1956, first as an isolate from a laboratory chimpanzee displaying symptoms of the common cold and later from infants suffering from respiratory disease. The most common clinical scenario for RSV is an upper respiratory tract infection that is typically mild and self-limiting. However, RSV is the leading cause of lower respiratory tract infections (LRTIs) in infants, with a peak age of hospitalization occurring at ages two...
-
Sector Analysis
Seasonal Influenza Prophylactics Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Seasonal Influenza Prophylactics Marketed and Pipeline Drugs Report Overview Influenza, often referred to as the flu, is an acute infection caused by one of the three closely related viruses designated as influenza types A, B, and C. These three types are members of the Orthomyxoviridae family and are structurally related. The Seasonal Influenza Prophylactics marketed and pipeline drugs market research report includes an assessment of the disease epidemiology, leading marketed products with sales forecast, pricing and reimbursement, late-to-mid-stage pipeline products...
-
Product Insights
Cellulitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Cellulitis Clinical Trials Market Report Overview The Cellulitis Clinical Trial provides an overview of Cellulitis Clinical trials scenario. The report provides top line data relating to the clinical trials on Lupus Nephritis. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type.
-
Product Insights
Kaposi Sarcoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Kaposi Sarcoma Clinical Trials Market Report Overview The Kaposi Sarcoma Clinical Trial provides an overview of Kaposi Sarcoma Clinical trials scenario. The report provides top line data relating to the clinical trials on Kaposi Sarcoma. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type.
-
Product Insights
Malaria Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Malaria Clinical Trials Market Report Overview The Malaria clinical trial market research report provides an overview of the Malaria clinical trials scenario. The report provides top-line data relating to the clinical trials on Malaria. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
-
Product Insights
Herpes Zoster (Shingles) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Herpes Zoster Clinical Trials Market Report Overview The herpes zoster (shingles) clinical trial market research report provides an overview of the herpes zoster (shingles) clinical trials scenario. The report provides top-line data relating to the clinical trials on herpes zoster (shingles). It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status,...
-
Product Insights
Vancomycin-Resistant Staphylococcus Aureus (VRSA) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
VRSA Infections Pipeline Drugs Market Report Overview Vancomycin-resistant staphylococcus infection is a condition caused by bacteria (germs). This infection occurs when bacteria, called Staphylococcus aureus or Staph, become resistant (not killed) to the antibiotic medicine vancomycin. Risk factors include taking strong antibiotics the wrong way may cause the bacteria to develop resistance to the antibiotics, a weak immune system, and staying in the hospital too long. Symptoms include fever, chills, cough, chest pain, trouble breathing, and a fast heartbeat. The...
-
Product Insights
Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
HA-MRSA Infections Pipeline Drugs Market Report Overview Hospital-acquired methicillin-resistant staphylococcus aureus (HA-MRSA) is acquired in the hospital setting. Symptoms include warmth to the touch, fever, and swollen, painful red bumps. Risk factors include being hospitalized, having an invasive medical device, and residing in a long-term care facility. This can be prevented by antibiotics and following hygiene procedures. The HA-MRSA infections pipeline products market research report provides comprehensive information on the therapeutics under development for HA-MRSA infections, complete with analysis by...
-
Product Insights
Tinea pedis (Athlete Foot) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Tinea Pedis Pipeline Drugs Market Report Overview Athlete's foot, also known as tinea pedis, is a common foot infection caused by fungi called dermatophytes. Symptoms include dry flaking skin on the soles of the feet, unpleasant foot odor, and small itchy bubbles or blisters on the soles of the feet. Treatment includes antifungal medicines. The tinea pedis pipeline products market research report provides comprehensive information on the therapeutics under development for tinea pedis, complete with analysis by stage of development,...
-
Product Insights
Meningitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Meningitis Pipeline Drugs Market Report Overview Meningitis is the inflammation caused by viruses and bacteria on the protective membranes covering the brain and spinal cord. The cause of inflammation can be infection by viruses, bacteria, or other microorganisms, and less commonly by certain drugs. As the inflammation is in proximity to the brain and spinal cord, meningitis can be life-threatening. Viral meningitis is not life-threatening and the people affected with this can be cured and recover quickly, but bacterial meningitis...
-
Product Insights
Toxoplasmosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Toxoplasmosis Pipeline Drugs Market Report Overview Toxoplasmosis is a disease that results from infection with the Toxoplasma gondii parasite. Symptoms include body aches, swollen lymph nodes, headache, fever, and fatigue. Risk factors include HIV/AIDS, chemotherapy, and immunosuppressant drugs. Treatment includes an antimalarial drug and antibiotics. The toxoplasmosis pipeline products market research report provides comprehensive information on the therapeutics under development for toxoplasmosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and...
-
Product Insights
Middle East Respiratory Syndrome (MERS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Middle East Respiratory Syndrome (MERS) Pipeline Drugs Market Report Overview Middle East respiratory syndrome (MERS) is a viral respiratory disease caused by a coronavirus (MERS-CoV). Symptoms include fever, cough, and shortness of breath. Other symptoms include nausea, vomiting and diarrhea. The MERS pipeline drugs market research report provides comprehensive information on the MERS targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also reviews key players...
-
Product Insights
Dengue Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Dengue Fever Pipeline Drugs Market Report Overview Dengue is a mosquito borne infectious disease caused by the dengue virus. Symptoms include a high fever, headaches, joint and muscle pain, vomiting, and a rash. In some cases, dengue turns into dengue hemorrhagic fever, which causes bleeding from nose, gums, or under skin. It can also become dengue shock syndrome, which causes massive bleeding and shock. Treatment includes use of analgesics, fluid replacement therapy and healthy life style. The dengue fever pipeline...
-
Product Insights
Zika Virus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Zika Virus Infections Pipeline Drugs Market Report Overview Zika virus infection is caused by a virus transmitted primarily by Aedes mosquitoes. Symptoms include fever, skin rashes, conjunctivitis, muscle and joint pain, malaise, and headache. Risk factors include being in tropical and subtropical areas. Zika virus can be transmitted through sexual intercourse. Treatment is aimed at relieving symptoms (joint pain and fever) with fluids and medications. The Zika Virus Infections pipeline drugs market research report provides comprehensive information on the Zika...
-
Product Insights
Influenza A Virus, H7N9 Subtype Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Influenza A Virus, H7N9 Subtype Infections Pipeline Drugs Market Report Overview Avian influenza A (H7N9) is a subtype of influenza viruses. This infection is seen both in humans and birds. Infection is caused when a person is exposure to infected poultry or contaminated environments. Symptoms include fever, cough that produces sputum, headache, myalgia, and general malaise. Treatment includes antiviral drugs. The Influenza A Virus, H7N9 Subtype Infections pipeline drugs market research report provides comprehensive information on the Influenza A Virus,...
-
Product Insights
Poliomyelitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Poliomyelitis Pipeline Drugs Market Report Overview Polio is a highly infectious disease caused by a virus. It invades the nervous system and causes total paralysis in a matter of hours. Symptoms include fever, fatigue, headache, vomiting, stiffness in the neck and pain in the limbs. Preventive measures such as the use of vaccines are effective for polio. The Poliomyelitis pipeline drugs market research report provides comprehensive information on the Poliomyelitis targeted therapeutics, complete with analysis by indications, stage of development,...
-
Product Insights
Eastern Equine Encephalitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Eastern Equine Encephalitis Pipeline Drugs Market Report Overview The Eastern Equine Encephalitis pipeline drugs market research report provides comprehensive information on the Eastern Equine Encephalitis targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also reviews key players involved in Eastern Equine Encephalitis targeted therapeutics development with respective active and dormant or discontinued projects.
-
Product Insights
Western Equine Encephalitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Western Equine Encephalitis Drugs Development Market Report Overview Western equine encephalitis is a disease that is spread to humans by infected mosquitoes. Western equine encephalitis is caused by the western equine encephalitis virus, an arbovirus. Symptoms range from mild to severe and may include only fever and headache to encephalitis with delirium, disorientation, or coma. The western equine encephalitis pipeline drugs market research report provides comprehensive information on the therapeutics under development for western equine encephalitis, complete with analysis by...
-
Product Insights
Influenzavirus B Infections Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Influenzavirus B Infections Clinical Trials Market Report Overview The influenzavirus B infections clinical trial market research report provides an overview of the influenzavirus B infections clinical trials scenario. The report provides top-line data relating to the clinical trials on influenzavirus B infections. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points...
-
Sector Analysis
Seasonal Influenza Therapeutics (SIT) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Seasonal Influenza Therapeutics (SIT) Marketed and Pipeline Drugs Report Overview Influenza, often referred to as the flu, is an acute infection caused by one of the three closely related viruses designated as influenza types A, B, and C. Â Influenza infection is normally self-limiting. Symptoms generally last for one to two weeks, but most people infected with influenza do not need or seek medical treatment. The Seasonal Influenza Therapeutics (SIT) marketed and pipeline drugs market research report provides a data-driven overview...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.